Cargando…
What the oncologist needs to know about COVID-19 infection in cancer patients
Autores principales: | Rassy, Elie, Khoury-Abboud, Rita-Maria, Ibrahim, Nathalie, Kattan, Clarisse, Assi, Tarek, Kattan, Joseph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Medicine Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7192200/ https://www.ncbi.nlm.nih.gov/pubmed/32323577 http://dx.doi.org/10.2217/fon-2020-0312 |
Ejemplares similares
-
The management of patients with metastatic prostate cancer during the COVID-19 pandemic
por: Assi, Tarek, et al.
Publicado: (2020) -
Do checkpoint inhibitors compromise the cancer patients’ immunity and increase the vulnerability to COVID-19 infection?
por: Kattan, Joseph, et al.
Publicado: (2020) -
The impact of the coronavirus pandemic on the management of cancer patients in Lebanon: a single institutional experience
por: Kattan, Clarisse, et al.
Publicado: (2020) -
Learning by Debate: Innovative Tool in the Hematology-Oncology Fellowship Program
por: Samaha, Ramy, et al.
Publicado: (2021) -
Solitary Laryngeal Metastasis from Transitional Cell Carcinoma of the Kidney: Clinical Case and Review of the Literature
por: Assi, Tarek, et al.
Publicado: (2015)